We are live on ! Find out more
GWM

Geneos Wealth Management Portfolio holdings

AUM $4.9B
1-Year Est. Return 23.65%
This Fund
S&P 500
This Quarter Est. Return
-0.95%
1 Year Est. Return
+23.65%
3 Year Est. Return
+66.72%
5 Year Est. Return
+71.27%
10 Year Est. Return
+298.51%
AUM
$2.61B
AUM Growth
+$46.3M
Cap. Flow
+$79.5M
Cap. Flow %
3.04%
Top 10 Hldgs %
18.89%
Holding
2,951
New
108
Increased
848
Reduced
537
Closed
120

Top Buys

Rank Stock Value
1
ISTB icon
iShares Core 1-5 Year USD Bond ETF
ISTB
+$22.6M
2
BIV icon
Vanguard Intermediate-Term Bond ETF
BIV
+$22.6M
3
ROM icon
ProShares Ultra Technology
ROM
+$20.9M
4
BIB icon
ProShares Ultra NASDAQ Biotechnology
BIB
+$20.5M
5
USD icon
ProShares Ultra Semiconductors
USD
+$19.9M

Top Sells

Rank Stock Value
1
NEAR icon
iShares Short Maturity Bond ETF
NEAR
+$27.3M
2
SSO icon
ProShares Ultra S&P500
SSO
+$21.7M
3
DIG icon
ProShares Ultra Energy
DIG
+$21M
4
UYG icon
ProShares Ultra Financials
UYG
+$20.8M
5
BNDX icon
Vanguard Total International Bond ETF
BNDX
+$17M

Sector Composition

Rank Sector Weight
1 Technology 8.27%
2 Financials 5.92%
3 Consumer Discretionary 5.43%
4 Healthcare 4.85%
5 Industrials 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SRL icon
2901
Scully Royalty
SRL
$87.1M
– –
-87
Closed -$1K
STRO icon
2902
Sutro Biopharma
STRO
$421M
– –
-70
Closed -$13K
TCMD icon
2903
Tactile Systems Technology
TCMD
$665M
– –
-100
Closed -$5K
TCRT icon
2904
Alaunos Therapeutics
TCRT
$4.86M
– –
-3
Closed -$1K
TEX icon
2905
Terex
TEX
$7.74B
– –
-100
Closed -$4K
TKR icon
2906
Timken Company
TKR
$9.03B
– –
-36
Closed -$2K
TMAT icon
2907
Main Thematic Innovation ETF
TMAT
$254M
– –
-577
Closed -$13K
TQQQ icon
2908
ProShares UltraPro QQQ
TQQQ
$37.9B
– –
-1,428
Closed -$45K
TRX icon
2909
TRX Gold Corp
TRX
$344M
– –
-30,500
Closed -$15K
UTHR icon
2910
United Therapeutics
UTHR
$23.1B
– –
-24
Closed -$4K
UYG icon
2911
ProShares Ultra Financials
UYG
$847M
– –
-331,138
Closed -$20.8M
VSTM icon
2912
Verastem
VSTM
$610M
– –
-25
Closed -$1K
XERS icon
2913
Xeris Biopharma Holdings
XERS
$1.45B
– –
-1,000
Closed -$4K
YCBD icon
2914
cbdMD
YCBD
$5.93M
– –
-9
Closed -$9K
ZEPP
2915
Zepp Health
ZEPP
$69.7M
– –
-147
Closed -$6K
GPUS
2916
Hyperscale Data Inc
GPUS
$55.4M
– –
0
– -$2K
NAGE
2917
Niagen Bioscience
NAGE
$247M
– –
-2,950
Closed -$27K
CTLT
2918
DELISTED
CATALENT, INC.
CTLT
– –
-100
Closed -$11K
RNLX
2919
DELISTED
Renalytix plc American Depositary Shares
RNLX
– –
-440
Closed -$12K
GTHX
2920
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
– –
-300
Closed -$6K
EMFQ
2921
DELISTED
Amplify Emerging Markets FinTech ETF
EMFQ
– –
-22
Closed -$1K
VIA
2922
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
– –
-540
Closed -$31K
ARCE
2923
DELISTED
Arco Platform Limited Class A Common Shares
ARCE
– –
-100
Closed -$3K
SCPL
2924
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
– –
-750
Closed -$12K
HEXO
2925
DELISTED
HEXO Corp. Common Shares
HEXO
– –
-14
Closed -$1K
115 116
117
118 119

Similar funds

KCM
Kensico Capital Management Greenwich, Connecticut $4.9B AUM 41.26% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
FC
Freemont Capital Singapore $4.91B AUM 5.45% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
MCM
Moore Capital Management New York $4.92B AUM 35.4% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return
MCCA
Mill Creek Capital Advisors Conshohocken, Pennsylvania $4.87B AUM 17.69% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return

Geneos Wealth Management's Q3 2021 Portfolio in Review

As of Q3 2021, Geneos Wealth Management held 2,951 positions worth $2.61B, up 1.8% from $2.56B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Geneos Wealth Management deployed $79.5M of net new capital in Q3 2021, opening 108 new positions and adding to 848 existing holdings. Its largest new stake was ProShares Ultra Semiconductors: 2,223,832 shares worth $19.1M.

By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 8.2% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was iShares Short Maturity Bond ETF, an estimated $27.3M trimmed.

  • Geneos Wealth Management's largest Q3 2021 buy was ProShares Ultra Semiconductors: 2,223,832 shares worth $19.1M.
  • Geneos Wealth Management added most to iShares Core 1-5 Year USD Bond ETF in Q3 2021, an estimated $22.6M increase.
  • Geneos Wealth Management's biggest Q3 2021 reduction was iShares Short Maturity Bond ETF, cutting an estimated $27.3M.
  • Geneos Wealth Management fully exited ProShares Ultra Energy in Q3 2021, selling an estimated $21M.
  • Geneos Wealth Management's ten largest holdings make up 19% of its $2.61B portfolio in Q3 2021.
  • Geneos Wealth Management opened 108 new positions and closed 120 in Q3 2021.
  • Geneos Wealth Management's portfolio value rose 1.8% quarter-over-quarter to $2.61B.

Based on Geneos Wealth Management's 13F filing for Q3 2021, filed 9 Nov 2021.